Author: Marie Jones

Maculus Therapeutix, a preclinical-stage biopharmaceutical company which has developed a SINGLE injection delivery platform for diseases such as wet AMD (Age-related Macular Degeneration) and DME (Diabetic Macular Edema) instead of the standard 8-12 monthly injections, is pleased to welcome Privity FZ LLE as a partner and advisor for upcoming fundraising activities. Maculus plans to raise USD3 million with a USD8 million valuation for a 12-18 month period, including initial in-vivo animal studies and completion of in-vitro / in-vivo drug elution studies. Maculus achieved the breakthrough using a patented novel tunable biodegradable proprietary product, MacuBloc, capable of delivering any FDA approved…

TOKYO, Feb 19, 2021 – (JCN Newswire) – After making a near-perfect start to the 2021 season on Rallye Monte-Carlo last month, the TOYOTA GAZOO Racing World Rally Team will target another strong result on Arctic Rally Finland on 26-28 February. Making its debut in the FIA World Rally Championship, the event takes the place of the cancelled Rally Sweden as the season’s only pure winter round. The team will travel north from its base in central Finland aiming to continue the strong record of the Toyota Yaris WRC on snow and ice, having claimed three victories in Sweden in…

Blockpass, the pioneer of On-chain KYC(TM), is excited to announce the latest in a number of new partners for 2021: QTUM. Through this new partnership, QTUM and Blockpass will be working together to offer revolutionary On-chain KYC solutions to the QTUM ecosystem. In the spirit of blockchain technology, both Blockpass and QTUM will work in the most transparent way to support the space; this will include QTUM offering subsidies to specific members of the ecosystem looking to achieve regulatory compliance with On-chain KYC(TM) solutions. Blockpass is a digital identity verification provider which provides a one-click compliance gateway to financial services…

CUBERZ is the first Israeli, first female-led venture company to join hands with Privity FZ LLE, an independent venture-focused advisory firm in the UAE, after the normalization of the Abraham Accords last year. CUBERZ was launched in Tel Aviv by Nektar Solomon, CEO, and Ari Margalit, CSTO, and is developing a unique online marketplace aiming to change the way local craftsmen and small furniture manufacturers interact with potential customers, while proceeding to its seed round of venture capital fundraising. Ms Solomon commented: “We excited to start our journey with Privity as a stakeholder. It is truly amazing to find a…

The first to market predictive analytics product for SKAdNetwork will be available in early spring AppsFlyer, the global attribution leader, today announced the upcoming launch of PredictSK, a new predictive analytics solution that will be a part of its robust SKAdNetwork suite, SK360. The new product will be available after Apple will start enforcing its AppTrackingTransparency framework in early spring. The SK360 suite will continue to support the ecosystem throughout Apple’s upcoming privacy updates. SKAdNetwork is about to become a major part of campaign measurement and optimization on iOS, following Apple’s latest privacy changes. This deterministic attribution framework provides advertisers…

Per the CDC, NIOSH, and National Personal Protective Technology Laboratory Certified Equipment List, ALG Health is one of only three companies who manufacture their own mask that hold this rating. ALG Health announced today that it received National Institute of Occupational Safety and Health (NIOSH) Surgical N95 approval for three of its Made in the U.S.A. Patriot Masks. The approvals are for the ALG Health Foldable N95 Respirator and both sizes of their Molded N95 Respirators. The surgical ratings state these products are approved and cleared for use in Healthcare settings under Food & Drug Administration (FDA)/NIOSH MOU 225-18-006 regulations.…

Cofttek Holding Limited, a Chinese pharmaceutical manufacturer, has recently drawn the attention of investors, following the U.S. introduction of the FDA drug ultramicronized Palmitoylethanolamide (PEA) for COVID-19 patients. Cofttek is China’s largest manufacturer of ultramicronized Palmitoylethanolamide (PEA) raw materials. Following the U.S. news, orders at Cofttek have surged, and production capacity has been saturated. Cofttek founder Dr. Zeng explained, “Following this FDA news, the share price of FSD Pharma (NASDAQ: HUGE), our main competitor in the USA, roared from $3 to $14 in a few days. As the largest PEA manufacturer in China, Cofttek has attracted similar attention from many…

On 4 February 2021, the 17th edition of the FIFA Club World Cup(TM) officially kicked off in Qatar, with top football clubs from five continents gathered in Doha. Among them are UEFA Champions League winners FC Bayern Munchen and host country representatives Al-Duhail SC, with other teams including SE Palmeiras from Brazil, Ulsan Hyundai FC from the Korea Republic, Mexican team Tigres UANL and Egyptian side Al Ahly SC. They will present a feast of football for fans around the world. Joining hands with Mowasalat (Karwa), Qatar’s major transportation service provider, Yutong Bus will be devoted to serving FIFA Club…

AI-assisted computing has greatly improved the efficiency of new drug research and development. Suntrap Life Technologies Co., Ltd has taken the lead to establish the Suntrap IDDNU(R) platform to serve as an international drug discovery network alliance. In 2019, Suntrap Life Technologies established a drug research team, carried out comprehensive drug research and development projects, and built the Suntrap IDDNU (Suntrap International Drug Discovery Network Alliance) technology platform. Suntrap IDDNU is based upon the EK-DRD database, published by one of the researchers, Mr. Jason Zhao. (J Chem Inf Model. 2019 Sep 23;59(9):3619-3624. EK-DRD: A Comprehensive Database for Drug Repositioning Inspired…

On the morning of February 4, a press conference themed ‘Foreseeing the Future in Longhua, Shenzhen’ was held in Shenzhen Citizen Center. Longhua District will launch an all-round future city scenes experiment, make every effort to build a future city development experimental field and ideal society showcase window, and take the lead in exploring the system and path to adapt to the future development of high-density urban areas. This year is the opening year of the 14th Five-Year Plan. With the new starting point, Longhua District is launching the all-round future city scene experiment, another important innovation building Shenzhen into…

TOKYO, Feb 12, 2021 – (JCN Newswire) – Showa Denko (SDK; TSE: 4004) announces that it revises its forecast of consolidated business results for the year ending on December 31, 2020, which was announced on August 12, 2020, taking the latest economic conditions into consideration. SDK also announces that it will record losses due to impairment (extraordinary losses) in its 2020 consolidated financial statements. 1. Revision of forecast of consolidated business results for January 1 – December 31, 2020 (1) Revised forecast of consolidated business results for January 1 – December 31, 2020 * See www.sdk.co.jp/assets/files/english/news/2021/20210212_sdknewsrelease_e.pdf (2) Reasons for the revision Our forecast for net…

Apollomics, Inc., an innovative biopharmaceutical company committed to the discovery and development of mono- and combination- oncology therapies, today announced an exclusive license agreement for the development and commercialization of TYG100 in Mainland China, Hong Kong, Macau and Taiwan, also known as Greater China, and South Africa. TYG100 is an antigen-specific, active checkpoint control immunotherapy (ACCI) recombinant vaccine comprising the amino-terminal sequence of G17, a gastrointestinal peptide hormone, and utilizes the S-TIR(TM) technology platform. This technology induces a novel mechanism of action that is able to unmask tumors. TYG100 was developed by TYG oncology Ltd. based in the United Kingdom…

TOKYO, Feb 12, 2021 – (ACN Newswire) – JCB Co., Ltd. and Keychain GK have developed a novel infrastructure for processing credit-based micropayments between IoT devices. The innovation promises to enable direct human-to-machine and machine-to-machine payments at scale without the confines of credit cards. As new networks, such as 5G, deploy and the use of Internet of Things (IoT) devices grow, so will the need for automated and machine-to-machine micropayments. Mobile payment apps enabled the common mobile user to pay with their phone, however the current payment infrastructure does not support tens of billions of IoT devices. Use cases in point: electric vehicles automatically…

Elastomers are the soft, elastic materials, like gels and rubbers, that are found in automobile and airplane parts, in sports equipment, and are used to protect precision machinery and buildings against vibrations. Scientists now want to make them thinner and tougher, without losing elasticity. Nagoya University materials engineer Yukikazu Takeoka and colleagues reviewed the most recent efforts towards improving elastomers for the journal Science and Technology of Advanced Materials. Elastomers are made of many, long molecular chains of repeating subunits. They can undergo large deformations when stretched, returning to their original shape when the tension is released. They can do…

In anticipation of Centrality’s staking support, Moonstake has successfully launched the world’s first CENNZ validator. Moonstake will be the first wallet in the world to support CENNZ staking. Moonstake successfully completed the API connection to CENNZnet and has been preparing for development for staking support. Moonstake’s wallet supports holding, sending and receiving CENNZ, Centrality’s native token and it will soon provide staking functions. Once staking support is available, Moonstake users will be able to stake through the Moonstake wallet and receive CPAY as staking rewards. Moonstake started in the staking business last year with the aim to create the largest…

Cedar Clinical Research to be Evaluated to Support Phase IIb Trial of Novel PTSD Treatment Novamind Inc. (CSE:NM) (“Novamind”), a leading mental health company specialized in psychedelic medicine, is pleased to announce that it has made a strategic investment of AU$827,486 (approximately CAN$810,000, the “Strategic Investment”), in Bionomics Limited (“Bionomics”) (ASX:BNO)(OTCQB:BNOEF) (Germany:AU000000BNO5), a biopharmaceutical company dedicated to developing better treatments for central nervous system disorders. In addition, Cedar Clinical Research (“CCR”), a wholly owned subsidiary of Novamind based in Springville, Utah, will be evaluated by Bionomics as a clinical research site to conduct Bionomics’ Phase IIb trial examining BNC210. BNC210…

Apollomics, Inc., an innovative biopharmaceutical company committed to the discovery and development of mono- and combination- oncology therapies, and Iterion Therapeutics, Inc., a venture-backed, clinical stage biotechnology company developing novel cancer therapeutics, today announced an exclusive collaboration and license agreement for the development and commercialization of tegavivint in Mainland China, Hong Kong, Macau and Taiwan, also known as Greater China. Tegavivint is a potent and selective inhibitor of nuclear Beta-catenin that works through binding to TBL1 (Transducin Beta-like Protein One), a downstream target in the Wnt-signaling pathway. Iterion is pursuing the development of Tegavivint for the treatment of cancers where…

ZALL Group, Asia’s leading B2B e-commerce group, has officially opened its first overseas all-in-one Chinese bookstore on 8 February 2021 that is situated right in the heart of Orchard Road at Wheelock Place. The bookstore comprises of a cafe, art gallery and craft store, as well as event and outdoor spaces. Aspiring to create an all-in-one lifestyle experience, ZALL Bookstore seeks to create the perfect quintessential conducive environment for like-minded individuals who are passionate about Chinese culture, literature and arts to congregate and interact. “Perfect for enthusiasts who are keen to learn more about Chinese culture, ZALL Bookstore creates a…

On February 8, Joy Spreader published an announcement to alert that its results in 2020 would achieve substantial growth over 2019. According to the announcement, the Company’s revenue in 2020 is expected to range from approximately HK$880 million to HK$920 million, an increase ranging from around 63.6% to 71.0% as compared to 2019. The gross profit is expected to range from roughly HK$260 million to HK$300 million, an increase ranging from approximately 95.5% to 125.6% as compared to 2019. The profit before exchange gains and losses is expected to range from roughly HK$170 million to HK$200 million, representing an increase…

Apollomics licenses worldwide rights (ex-China, Hong Kong and Taiwan) to develop and commercialize EO1001 EO1001 is an irreversible, pan-erbB inhibitor of EGFR (ErbB1), HER2 (ErbB2) and HER4 (ErbB4) Apollomics, Inc., an innovative biopharmaceutical company committed to the discovery and development of mono- and combination- oncology therapies, and Edison Oncology Holding Corp., today announced that Apollomics has been granted worldwide rights, excluding China, Hong Kong and Taiwan, for the development and commercialization of EO1001. EO1001 is a protein tyrosine kinase inhibitor (TKI) that has demonstrated irreversible inhibition of EGFR (ErbB1), HER2 (ErbB2) and HER4 (ErbB4) as a single agent. “We are…